Trialbee and uMotif Expand Patient Access to Global Trials
Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are partnering hoping to improve the patient experience and improve trial accessibility globally. The companies’ integrated platforms simplify trial activities from initial awareness through enrollment and data collection during study conduct and close-out.
Patients are digitally matched to study protocols via Trialbee HIVE. Qualified, study-ready patients are then consented at-site or remotely through the Trialbee platform, which is integrated with uMotif’s application. Once enrolled, patients use the engaging uMotif app to capture large volumes of ePRO, eDiary and symptom data in real-time throughout the duration of a trial. Patients are empowered to manage and collect their data in an application, while sponsors receive an understanding of patient symptoms and behavior.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
